What does the research say about Recurrent myocardial infarction?

Recurrent myocardial infarction

There are 12 papers on recurrent myocardial infarction in aging research: 11 observational studies in people, 1 review. The newest story, Oct 26, 2026: “Beta-blockers tied to fewer deaths in selected heart attack patients”.

Disease

12 papers study it23 more mention it4 findings

4 new papers in 30 daysSee all 35

“except that using RASI and a beta-blocker without a statin was associated with a lower risk of recurrent MI (HR 0.85; 95% CI, 0.75-0.96)”

Secondary prevention of myocardial infarction in people with dementia: a multi-jurisdictional retrospective cohort study in Asia, Europe and the USAAge and ageing2026doi:10.1093/ageing/afag220

Humans11

Interventions

Beta-blockers

no changein humans1

1 study

Beta-blockers were not clearly linked with recurrent myocardial infarction in humans (elderly patients without left ventricular systolic dysfunction following PCI for acute MI).
“There were no significant differences between the two groups in the risks of recurrent MI, any revascularization, readmission due to HF, stroke, or definite/probable ST.”
Humanselderly patients without left ventricular systolic dysfunction following PCI for acute MImedian follow-up of 998 daysn = 2,566
Beta-blockers tied to fewer deaths in selected heart attack patients
ESC Congress 2026 abstractOct 26, 2026

Associations

Renin-angiotensin system inhibitors plus beta-blockers

downin humans1HR 0.85

1 study

Renin-angiotensin system inhibitors plus beta-blockers are linked with a lower risk of recurrent myocardial infarction in humans (without statin, compared with all three medications, in people with dementia) (HR 0.85; 95% CI 0.75-0.96).
“except that using RASI and a beta-blocker without a statin was associated with a lower risk of recurrent MI (HR 0.85; 95% CI, 0.75-0.96)”
Humanswithout statin, compared with all three medications, in people with dementia
Secondary prevention of myocardial infarction in people with dementia: a multi-jurisdictional retrospective cohort study in Asia, Europe and the USA
Age and ageingAug 3, 2026

More on Renin-angiotensin system inhibitors plus beta-blockers

Body mass index

downin humans1HR 0.965

1 study

Body mass index is linked with a lower risk of recurrent myocardial infarction in humans (acute myocardial infarction) (adjusted HR = 0.965, 95% CI 0.936-0.994, P = 0.018).
“In the ≤60 years group, higher BMI was associated with a significantly lower risk of recurrent myocardial infarction [adjusted hazard ratio (HR) = 0.965, 95% confidence interval (CI) 0.936-0.994, P = 0.018].”
Humansacute myocardial infarctionmedian follow-up 35 monthsn = 1,277
Age-dependent obesity paradox in acute myocardial infarction prognosis: a cohort study of body mass index and recurrent myocardial infarction
International journal of obesity (2005)Feb 28, 2026

Latest

16 papers in 12 months

ESC Congress 2026 AbstractOct 26

Beta-blockers tied to fewer deaths in selected heart attack patients

Major heart complications occurred in 20.9% of patients taking beta-blockers compared with 25.4% without them over a median follow-up of 998 days.Major heart complications occurred in 20.9% of patients taking beta-blockers compared with 25.4% without them over a median follow-up of 998 days.

Cohort · 2,566 peopleBeta-blockers